66 related articles for article (PubMed ID: 38731914)
1. Distinct Driver Pathway Enrichments and a High Prevalence of
Tapia-Valladares C; Valenzuela G; González E; Maureira I; Toro J; Freire M; Sepúlveda-Hermosilla G; Ampuero D; Blanco A; Gallegos I; Morales F; Erices JI; Barajas O; Ahumada M; Contreras HR; González J; Armisén R; Marcelain K
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731914
[TBL] [Abstract][Full Text] [Related]
2. Decoding complex inherited phenotypes in rare disorders: the DECIPHERD initiative for rare undiagnosed diseases in Chile.
Poli MC; Rebolledo-Jaramillo B; Lagos C; Orellana J; Moreno G; Martín LM; Encina G; Böhme D; Faundes V; Zavala MJ; Hasbún T; Fischer S; Brito F; Araya D; Lira M; de la Cruz J; Astudillo C; Lay-Son G; Cares C; Aracena M; Martin ES; Coban-Akdemir Z; Posey JE; Lupski JR; Repetto GM
Eur J Hum Genet; 2024 Jan; ():. PubMed ID: 38177409
[TBL] [Abstract][Full Text] [Related]
3. Gallbladder Cancer Risk and Indigenous South American Mapuche Ancestry: Instrumental Variable Analysis Using Ancestry-Informative Markers.
Zollner L; Boekstegers F; Barahona Ponce C; Scherer D; Marcelain K; Gárate-Calderón V; Waldenberger M; Morales E; Rojas A; Munoz C; Retamales J; De Toro G; Kortmann AV; Barajas O; Rivera MT; Cortés A; Loader D; Saavedra J; Gutiérrez L; Ortega A; Bertrán ME; Bartolotti L; Gabler F; Campos M; Alvarado J; Moisán F; Spencer L; Nervi B; Carvajal D; Losada H; Almau M; Fernández P; Olloquequi J; Carter AR; Miquel Poblete JF; Bustos BI; Fuentes Guajardo M; Gonzalez-Jose R; Bortolini MC; Acuña-Alonzo V; Gallo C; Ruiz Linares A; Rothhammer F; Lorenzo Bermejo J
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627062
[TBL] [Abstract][Full Text] [Related]
4. LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance.
Zhai X; Xia Z; Du G; Zhang X; Xia T; Ma D; Li X; Jin B; Zhang H
Genes Dis; 2023 Sep; 10(5):2082-2096. PubMed ID: 37492741
[TBL] [Abstract][Full Text] [Related]
5. Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy: Guideline From the College of American Pathologists in Collaboration With the Association for Molecular Pathology and Fight Colorectal Cancer.
Bartley AN; Mills AM; Konnick E; Overman M; Ventura CB; Souter L; Colasacco C; Stadler ZK; Kerr S; Howitt BE; Hampel H; Adams SF; Johnson W; Magi-Galluzzi C; Sepulveda AR; Broaddus RR
Arch Pathol Lab Med; 2022 Oct; 146(10):1194-1210. PubMed ID: 35920830
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial.
Sartore-Bianchi A; Pietrantonio F; Lonardi S; Mussolin B; Rua F; Crisafulli G; Bartolini A; Fenocchio E; Amatu A; Manca P; Bergamo F; Tosi F; Mauri G; Ambrosini M; Daniel F; Torri V; Vanzulli A; Regge D; Cappello G; Marchiò C; Berrino E; Sapino A; Marsoni S; Siena S; Bardelli A
Nat Med; 2022 Aug; 28(8):1612-1618. PubMed ID: 35915157
[TBL] [Abstract][Full Text] [Related]
7. Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer.
Rinne N; Christie EL; Ardasheva A; Kwok CH; Demchenko N; Low C; Tralau-Stewart C; Fotopoulou C; Cunnea P
Cancer Drug Resist; 2021; 4(3):573-595. PubMed ID: 35582310
[TBL] [Abstract][Full Text] [Related]
8. Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Takenaka IKTM; Bartelli TF; Defelicibus A; Sendoya JM; Golubicki M; Robbio J; Serpa MS; Branco GP; Santos LBC; Claro LCL; Dos Santos GO; Kupper BEC; da Silva IT; Llera AS; de Mello CAL; Riechelmann RP; Dias-Neto E; Iseas S; Aguiar S; Nunes DN
Front Oncol; 2022; 12():809441. PubMed ID: 35392220
[TBL] [Abstract][Full Text] [Related]
9. The Genomics of Colorectal Cancer in Populations with African and European Ancestry.
Myer PA; Lee JK; Madison RW; Pradhan K; Newberg JY; Isasi CR; Klempner SJ; Frampton GM; Ross JS; Venstrom JM; Schrock AB; Das S; Augenlicht L; Verma A; Greally JM; Raj SM; Goel S; Ali SM
Cancer Discov; 2022 May; 12(5):1282-1293. PubMed ID: 35176763
[TBL] [Abstract][Full Text] [Related]
10. Targeting PI3K/Akt signal transduction for cancer therapy.
He Y; Sun MM; Zhang GG; Yang J; Chen KS; Xu WW; Li B
Signal Transduct Target Ther; 2021 Dec; 6(1):425. PubMed ID: 34916492
[TBL] [Abstract][Full Text] [Related]
11. Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies.
Zhou J; Ji Q; Li Q
J Exp Clin Cancer Res; 2021 Oct; 40(1):328. PubMed ID: 34663410
[TBL] [Abstract][Full Text] [Related]
12. Validation of an NGS Panel Designed for Detection of Actionable Mutations in Tumors Common in Latin America.
Salvo M; González-Feliú E; Toro J; Gallegos I; Maureira I; Miranda-González N; Barajas O; Bustamante E; Ahumada M; Colombo A; Armisén R; Villamán C; Ibañez C; Bravo ML; Sanhueza V; Spencer ML; de Toro G; Morales E; Bizama C; García P; Carrasco AM; Gutiérrez L; Bermejo JL; Verdugo RA; Marcelain K
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575676
[TBL] [Abstract][Full Text] [Related]
13. A prognostic predictive model constituted with gene mutations of
Zheng L; Zhan Y; Lu J; Hu J; Kong D
Ann Transl Med; 2021 Apr; 9(8):680. PubMed ID: 33987378
[TBL] [Abstract][Full Text] [Related]
14. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis.
Sawicki T; Ruszkowska M; Danielewicz A; Niedźwiedzka E; Arłukowicz T; Przybyłowicz KE
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33922197
[TBL] [Abstract][Full Text] [Related]
15. Phase II Clinical Trial of Everolimus in a Pan-Cancer Cohort of Patients with mTOR Pathway Alterations.
Adib E; Klonowska K; Giannikou K; Do KT; Pruitt-Thompson S; Bhushan K; Milstein MI; Hedglin J; Kargus KE; Sholl LM; Tsuji J; Hyman DM; Sisk A; Shapiro GI; Vargas HA; Harding JJ; Voss MH; Iyer G; Kwiatkowski DJ
Clin Cancer Res; 2021 Jul; 27(14):3845-3853. PubMed ID: 33727259
[TBL] [Abstract][Full Text] [Related]
16. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Al-Hawary MM; Arain MA; Chen YJ; Ciombor KK; Cohen S; Cooper HS; Deming D; Farkas L; Garrido-Laguna I; Grem JL; Gunn A; Hecht JR; Hoffe S; Hubbard J; Hunt S; Johung KL; Kirilcuk N; Krishnamurthi S; Messersmith WA; Meyerhardt J; Miller ED; Mulcahy MF; Nurkin S; Overman MJ; Parikh A; Patel H; Pedersen K; Saltz L; Schneider C; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Gregory KM; Gurski LA
J Natl Compr Canc Netw; 2021 Mar; 19(3):329-359. PubMed ID: 33724754
[TBL] [Abstract][Full Text] [Related]
17. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Sung H; Ferlay J; Siegel RL; Laversanne M; Soerjomataram I; Jemal A; Bray F
CA Cancer J Clin; 2021 May; 71(3):209-249. PubMed ID: 33538338
[TBL] [Abstract][Full Text] [Related]
18. Gallstones, Body Mass Index, C-Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data.
Barahona Ponce C; Scherer D; Brinster R; Boekstegers F; Marcelain K; Gárate-Calderón V; Müller B; de Toro G; Retamales J; Barajas O; Ahumada M; Morales E; Rojas A; Sanhueza V; Loader D; Rivera MT; Gutiérrez L; Bernal G; Ortega A; Montalvo D; Portiño S; Bertrán ME; Gabler F; Spencer L; Olloquequi J; Fischer C; Jenab M; Aleksandrova K; Katzke V; Weiderpass E; Bonet C; Moradi T; Fischer K; Bossers W; Brenner H; Hveem K; Eklund N; Völker U; Waldenberger M; Fuentes Guajardo M; Gonzalez-Jose R; Bedoya G; Bortolini MC; Canizales-Quinteros S; Gallo C; Ruiz-Linares A; Rothhammer F; Lorenzo Bermejo J
Hepatology; 2021 May; 73(5):1783-1796. PubMed ID: 32893372
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
